Skip to main content
. 2017 Jul 27;12(7):e0179726. doi: 10.1371/journal.pone.0179726

Table 1. RNA-seq based marker sets created and used in this study to estimate immune cell levels in tumors.

Signature Membership Description
TCD8 CD8A, CD8B CD8+ T cell
Treg FOXP3, CCR8 Regulatory T cell
Tcell CD3D, CD3E, CD2 T cell (general)
Bcell CD19, CD79A, MS4A1 B cell
NK KIR2DL1, KIR2DL3, KIR2DL4, KIR3DL1, KIR3DL2, KIR3DL3, KIR2DS4 Natural killer cell
Mono CD86, CSF1R, C3AR1 Monocyte
MFm2 CD163, VSIG4, MS4A4A M2 Macrophage
TregCD8 Treg, TCD8 Treg versus CD8+ T cell
NKCD8 NK, TCD8 NK versus CD8+ T cell